Dotmatics announces major expansion of biologics capabilities

Monday, November 6, 2017

Dotmatics, a provider of scientific informatics solutions and services, announced major global biologics capabilities and the addition of key personnel and workflows that allow discovery teams to capture experiments, processes, and improve decision-support based on a more comprehensive view of project data. The new workflows leverage Dotmatics Bioregister, Dotmatics Studies, Dotmatics Inventory, Dotmatics Browser, Dotmatics Vortex, Dotmatics Cascade and Dotmatics Studies Notebook.

[Read More]

3E, Dotmatics partner on scientific informatics and environmental compliance

Wednesday, January 18, 2017

3E Company, a provider of environmental health and safety (EH&S) compliance and information management services, has announced a strategic alliance with Dotmatics, a provider of scientific informatics solutions and services to the life sciences industry. The alliance will offer Dotmatics and 3E customers access to a range of integrated applications designed to optimize scientific information management, chemical and formula risk analysis, environmental compliance and workplace safety while helping to streamline processes, reduce costs and increase efficiency. Having access to reliable and up-to-date scientific and regulatory information enables life sciences businesses to improve knowledge management, data storage and decision support. 3E Company is a Verisk Analytics business.

[Read More]

Dotmatics, BioByte partner to speed drug candidate selection

Tuesday, April 5, 2016

Dotmatics, a provider of scientific informatics solutions and services to the life sciences industry, announced a partnership with BioByte, producer of the industry gold standard partition coefficient calculator (ClogP). This deal will enable users of the Dotmatics Platform including Vortex and Browser to calculate ClogP seamlessly within the applications. This will streamline the research process and speed up the selection of potential drug candidates.  

[Read More]

AstraZeneca selects Dotmatics platform

Monday, July 29, 2013

AstraZeneca’s Neuroscience Innovative Medicines Unit (iMed) has selected Dotmatics’ cloud based informatics platform as its research data management solution. The Dotmatics platform provides a single point of access to all data and functions across multidisciplinary groups. The platform includes compound registration and tracking, biological screening, DMPK analysis, fully integrated chemistry and biology ELN and project management to enable scientists, collaborators and partners to instantly interact with the same data regardless of location and time zone.

[Read More]